COX-2 inhibitors and other NSAIDs in bladder and prostate cancer

Prog Exp Tumor Res. 2003;37:163-78. doi: 10.1159/000071372.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Dietary Fats / adverse effects
  • Humans
  • Isoenzymes / analysis
  • Isoenzymes / antagonists & inhibitors*
  • Male
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases / analysis
  • Prostatic Neoplasms / enzymology
  • Prostatic Neoplasms / epidemiology
  • Prostatic Neoplasms / prevention & control*
  • Urinary Bladder Neoplasms / enzymology
  • Urinary Bladder Neoplasms / epidemiology
  • Urinary Bladder Neoplasms / prevention & control*

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Dietary Fats
  • Isoenzymes
  • Membrane Proteins
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases